Inogen (INGN) Income from Non-Controlling Interests (2016 - 2026)
Inogen's (INGN) quarterly Income from Non-Controlling Interests came in at $17000.0 in Q1 2026, up 139.53% on a QoQ basis from -$43000.0 in Q4 2025.
Inogen (INGN) Income from Non-Controlling Interests (2016 - 2026) Analysis & Trends
Inogen (INGN) has 11 years of Income from Non-Controlling Interests data on file, last reported at $17000.0 in Q1 2026.
- On a quarterly basis, Income from Non-Controlling Interests changed N/A year-over-year to $17000.0 in Q1 2026; TTM through Mar 2026 was $39000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $22000.0, up 116.18% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $17000.0, up from -$43000.0 in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for INGN reached as high as $203000.0 in Q3 2024 and fell as low as -$297000.0 in Q4 2024.
- Historically, Income from Non-Controlling Interests has averaged $2375.0 across 5 years, with a median of $13000.0 in 2022.
- Across the five-year window, Income from Non-Controlling Interests surged 1800.0% in 2022 and plunged 900.0% in 2023, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at $9000.0 in 2022, then plunged by 900.0% to -$72000.0 in 2023, then slumped by 312.5% to -$297000.0 in 2024, then surged by 85.52% to -$43000.0 in 2025, then jumped by 139.53% to $17000.0 in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $17000.0 in Q1 2026, -$43000.0 in Q4 2025, and $23000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | - |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Inogen | 174.30 Mn | 64.12 Mn | 37.86 Mn | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Dec 31, 2024 | -297,000.00 |
| Sep 30, 2024 | 203,000.00 |
| Jun 30, 2024 | -40,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -72,000.00 |
| Sep 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 64,000.00 |
| Mar 31, 2023 | 69,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Mar 31, 2022 | -8,000.00 |
| Dec 31, 2021 | -2.01 Mn |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -3,000.00 |
| Mar 31, 2021 | 4,000.00 |